Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081))

Lykke M. Ørnbjerg; Louise Linde; Stylianos Georgiadis; Simon H. Rasmussen; Ulf Lindström; Johan Askling; Brigitte Michelsen; Daniela Di Giuseppe; Johan K. Wallman; Karel Pavelka; Jakub Závada; Michael J. Nissen; Gareth T. Jones; Heikki Relas; Laura Pirilä; Matija Tomšič; Ziga Rotar; Arni Jon Geirsson; Bjorn Gudbjornsson; Eirik K. Kristianslund; Irene van der Horst-Bruinsma; Anne Gitte Loft; Karin Laas; Florenzo Iannone; Addolorata Corrado; Adrian Ciurea; Maria J. Santos; Helena Santos; Catalin Codreanu; Nurullah Akkoc; Ozgul S. Gunduz; Bente Glintborg; Mikkel Østergaard; Merete Lund Hetland

doi:https://doi.org/10.1016/j.semarthrit.2022.152141

Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081))

Lykke M. Ørnbjerg, Louise Linde, Stylianos Georgiadis, Simon H. Rasmussen, Ulf Lindström, Johan Askling, Brigitte Michelsen, Daniela Di Giuseppe, Johan K. Wallman, Karel Pavelka, Jakub Závada, Michael J. Nissen, Gareth T. Jones, Heikki Relas, Laura Pirilä, Matija Tomšič, Ziga Rotar, Arni Jon Geirsson, Bjorn Gudbjornsson, Eirik K. KristianslundIrene van der Horst-Bruinsma, Anne Gitte Loft, Karin Laas, Florenzo Iannone, Addolorata Corrado, Adrian Ciurea, Maria J. Santos, Helena Santos, Catalin Codreanu, Nurullah Akkoc, Ozgul S. Gunduz, Bente Glintborg, Mikkel Østergaard, Merete Lund Hetland

Research output: Contribution to journal › Comment/Letter to the editor › Academic

Abstract

The authors regret that the following incorrect values have been published in the original paper: In the abstract: Line 11-12: “age, per year: 0.97 (0.97-0.98)” should be “age, per year: 0.98 (0.97-0.99)” Line 12: “men vs. women: 1.88 (1.60-2.22)” should be “men vs. women: 1.79 (1.51-2.12)” Line 12: “current vs. non-smoking: 0.76 (0.63-0.91)” should be “current vs. non-smoking: 0.72 (0.59-0.87)” Line 12-13: “HLA-B27 positive vs. negative: 1.51 (1.20-1.91)” should be “HLA-B27 positive vs. negative: 1.65 (1.27-2.15)” Line 14: “CRP>10 vs. ≤10 mg/l: 1.49 (1.25-1.77)” should be “CRP>10 vs. ≤10 mg/l: 1.36 (1.14-1.62)” Line 15-16: “fatigue and spinal pain: 0.99 (0.99-1.00) and 0.99 (0.99-1.99)” should be “fatigue and spinal pain: 0.99 (0.99-0.99) and 0.99 (0.99-1.00)” In Table 3, row with EPV (row 3 after header/subheader): Column with header/subheader “Czech Republic/ATTRA”: EPV 15.9 should be 13.2 Column with header/subheader “Netherlands/ARC”: EPV 1 should be 1.0 Column with header/subheader “Portugal/Reuma.pt”: EPV 14.7 should be 13.1 Column with header/subheader “Romania/RRBR”: EPV 2.8 should be 2.4 Column with header/subheader “Turkey/TURKBIO”: EPV 12.9 should be 11.8 In Table 5, row with “Patient global score, mm” (row 10 counting from row with “Age at treatment start, years”): In the column with header: “Analysis of 12-month drug retention” and subheader: “Univariate”, the value for the odds ratio (OR) is missing. The OR should be 0.99. The authors would like to apologise for any inconvenience caused.

Original language	English
Article number	152141
Journal	Seminars in Arthritis and Rheumatism
Volume	58
DOIs	https://doi.org/10.1016/j.semarthrit.2022.152141
Publication status	Published - 1 Feb 2023

Access to Document

https://doi.org/10.1016/j.semarthrit.2022.152141

Cite this

Ørnbjerg, L. M., Linde, L., Georgiadis, S., Rasmussen, S. H., Lindström, U., Askling, J., Michelsen, B., Giuseppe, D. D., Wallman, J. K., Pavelka, K., Závada, J., Nissen, M. J., Jones, G. T., Relas, H., Pirilä, L., Tomšič, M., Rotar, Z., Geirsson, A. J., Gudbjornsson, B., ... Hetland, M. L. (2023). Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081)). Seminars in Arthritis and Rheumatism, 58, Article 152141. https://doi.org/10.1016/j.semarthrit.2022.152141

Ørnbjerg, Lykke M. ; Linde, Louise ; Georgiadis, Stylianos et al. / Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors : data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081)). In: Seminars in Arthritis and Rheumatism. 2023 ; Vol. 58.

@article{8fb12150542542f4926742795017cce8,

title = "Corrigendum to {\textquoteleft}Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration{\textquoteright} [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081))",

abstract = "The authors regret that the following incorrect values have been published in the original paper: In the abstract: Line 11-12: “age, per year: 0.97 (0.97-0.98)” should be “age, per year: 0.98 (0.97-0.99)” Line 12: “men vs. women: 1.88 (1.60-2.22)” should be “men vs. women: 1.79 (1.51-2.12)” Line 12: “current vs. non-smoking: 0.76 (0.63-0.91)” should be “current vs. non-smoking: 0.72 (0.59-0.87)” Line 12-13: “HLA-B27 positive vs. negative: 1.51 (1.20-1.91)” should be “HLA-B27 positive vs. negative: 1.65 (1.27-2.15)” Line 14: “CRP>10 vs. ≤10 mg/l: 1.49 (1.25-1.77)” should be “CRP>10 vs. ≤10 mg/l: 1.36 (1.14-1.62)” Line 15-16: “fatigue and spinal pain: 0.99 (0.99-1.00) and 0.99 (0.99-1.99)” should be “fatigue and spinal pain: 0.99 (0.99-0.99) and 0.99 (0.99-1.00)” In Table 3, row with EPV (row 3 after header/subheader): Column with header/subheader “Czech Republic/ATTRA”: EPV 15.9 should be 13.2 Column with header/subheader “Netherlands/ARC”: EPV 1 should be 1.0 Column with header/subheader “Portugal/Reuma.pt”: EPV 14.7 should be 13.1 Column with header/subheader “Romania/RRBR”: EPV 2.8 should be 2.4 Column with header/subheader “Turkey/TURKBIO”: EPV 12.9 should be 11.8 In Table 5, row with “Patient global score, mm” (row 10 counting from row with “Age at treatment start, years”): In the column with header: “Analysis of 12-month drug retention” and subheader: “Univariate”, the value for the odds ratio (OR) is missing. The OR should be 0.99. The authors would like to apologise for any inconvenience caused.",

author = "{\O}rnbjerg, {Lykke M.} and Louise Linde and Stylianos Georgiadis and Rasmussen, {Simon H.} and Ulf Lindstr{\"o}m and Johan Askling and Brigitte Michelsen and Giuseppe, {Daniela Di} and Wallman, {Johan K.} and Karel Pavelka and Jakub Z{\'a}vada and Nissen, {Michael J.} and Jones, {Gareth T.} and Heikki Relas and Laura Piril{\"a} and Matija Tom{\v s}i{\v c} and Ziga Rotar and Geirsson, {Arni Jon} and Bjorn Gudbjornsson and Kristianslund, {Eirik K.} and {van der Horst-Bruinsma}, Irene and Loft, {Anne Gitte} and Karin Laas and Florenzo Iannone and Addolorata Corrado and Adrian Ciurea and Santos, {Maria J.} and Helena Santos and Catalin Codreanu and Nurullah Akkoc and Gunduz, {Ozgul S.} and Bente Glintborg and Mikkel {\O}stergaard and Hetland, {Merete Lund}",

note = "Publisher Copyright: {\textcopyright} 2022 The Authors",

year = "2023",

month = feb,

day = "1",

doi = "https://doi.org/10.1016/j.semarthrit.2022.152141",

language = "English",

volume = "58",

journal = "Seminars in Arthritis and Rheumatism",

issn = "0049-0172",

publisher = "W.B. Saunders Ltd",

}

Ørnbjerg, LM, Linde, L, Georgiadis, S, Rasmussen, SH, Lindström, U, Askling, J, Michelsen, B, Giuseppe, DD, Wallman, JK, Pavelka, K, Závada, J, Nissen, MJ, Jones, GT, Relas, H, Pirilä, L, Tomšič, M, Rotar, Z, Geirsson, AJ, Gudbjornsson, B, Kristianslund, EK, van der Horst-Bruinsma, I, Loft, AG, Laas, K, Iannone, F, Corrado, A, Ciurea, A, Santos, MJ, Santos, H, Codreanu, C, Akkoc, N, Gunduz, OS, Glintborg, B, Østergaard, M & Hetland, ML 2023, 'Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081))', Seminars in Arthritis and Rheumatism, vol. 58, 152141. https://doi.org/10.1016/j.semarthrit.2022.152141

Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081)). / Ørnbjerg, Lykke M.; Linde, Louise; Georgiadis, Stylianos et al.
In: Seminars in Arthritis and Rheumatism, Vol. 58, 152141, 01.02.2023.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors

T2 - data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081))

AU - Ørnbjerg, Lykke M.

AU - Linde, Louise

AU - Georgiadis, Stylianos

AU - Rasmussen, Simon H.

AU - Lindström, Ulf

AU - Askling, Johan

AU - Michelsen, Brigitte

AU - Giuseppe, Daniela Di

AU - Wallman, Johan K.

AU - Pavelka, Karel

AU - Závada, Jakub

AU - Nissen, Michael J.

AU - Jones, Gareth T.

AU - Relas, Heikki

AU - Pirilä, Laura

AU - Tomšič, Matija

AU - Rotar, Ziga

AU - Geirsson, Arni Jon

AU - Gudbjornsson, Bjorn

AU - Kristianslund, Eirik K.

AU - van der Horst-Bruinsma, Irene

AU - Loft, Anne Gitte

AU - Laas, Karin

AU - Iannone, Florenzo

AU - Corrado, Addolorata

AU - Ciurea, Adrian

AU - Santos, Maria J.

AU - Santos, Helena

AU - Codreanu, Catalin

AU - Akkoc, Nurullah

AU - Gunduz, Ozgul S.

AU - Glintborg, Bente

AU - Østergaard, Mikkel

AU - Hetland, Merete Lund

PY - 2023/2/1

Y1 - 2023/2/1

N2 - The authors regret that the following incorrect values have been published in the original paper: In the abstract: Line 11-12: “age, per year: 0.97 (0.97-0.98)” should be “age, per year: 0.98 (0.97-0.99)” Line 12: “men vs. women: 1.88 (1.60-2.22)” should be “men vs. women: 1.79 (1.51-2.12)” Line 12: “current vs. non-smoking: 0.76 (0.63-0.91)” should be “current vs. non-smoking: 0.72 (0.59-0.87)” Line 12-13: “HLA-B27 positive vs. negative: 1.51 (1.20-1.91)” should be “HLA-B27 positive vs. negative: 1.65 (1.27-2.15)” Line 14: “CRP>10 vs. ≤10 mg/l: 1.49 (1.25-1.77)” should be “CRP>10 vs. ≤10 mg/l: 1.36 (1.14-1.62)” Line 15-16: “fatigue and spinal pain: 0.99 (0.99-1.00) and 0.99 (0.99-1.99)” should be “fatigue and spinal pain: 0.99 (0.99-0.99) and 0.99 (0.99-1.00)” In Table 3, row with EPV (row 3 after header/subheader): Column with header/subheader “Czech Republic/ATTRA”: EPV 15.9 should be 13.2 Column with header/subheader “Netherlands/ARC”: EPV 1 should be 1.0 Column with header/subheader “Portugal/Reuma.pt”: EPV 14.7 should be 13.1 Column with header/subheader “Romania/RRBR”: EPV 2.8 should be 2.4 Column with header/subheader “Turkey/TURKBIO”: EPV 12.9 should be 11.8 In Table 5, row with “Patient global score, mm” (row 10 counting from row with “Age at treatment start, years”): In the column with header: “Analysis of 12-month drug retention” and subheader: “Univariate”, the value for the odds ratio (OR) is missing. The OR should be 0.99. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the following incorrect values have been published in the original paper: In the abstract: Line 11-12: “age, per year: 0.97 (0.97-0.98)” should be “age, per year: 0.98 (0.97-0.99)” Line 12: “men vs. women: 1.88 (1.60-2.22)” should be “men vs. women: 1.79 (1.51-2.12)” Line 12: “current vs. non-smoking: 0.76 (0.63-0.91)” should be “current vs. non-smoking: 0.72 (0.59-0.87)” Line 12-13: “HLA-B27 positive vs. negative: 1.51 (1.20-1.91)” should be “HLA-B27 positive vs. negative: 1.65 (1.27-2.15)” Line 14: “CRP>10 vs. ≤10 mg/l: 1.49 (1.25-1.77)” should be “CRP>10 vs. ≤10 mg/l: 1.36 (1.14-1.62)” Line 15-16: “fatigue and spinal pain: 0.99 (0.99-1.00) and 0.99 (0.99-1.99)” should be “fatigue and spinal pain: 0.99 (0.99-0.99) and 0.99 (0.99-1.00)” In Table 3, row with EPV (row 3 after header/subheader): Column with header/subheader “Czech Republic/ATTRA”: EPV 15.9 should be 13.2 Column with header/subheader “Netherlands/ARC”: EPV 1 should be 1.0 Column with header/subheader “Portugal/Reuma.pt”: EPV 14.7 should be 13.1 Column with header/subheader “Romania/RRBR”: EPV 2.8 should be 2.4 Column with header/subheader “Turkey/TURKBIO”: EPV 12.9 should be 11.8 In Table 5, row with “Patient global score, mm” (row 10 counting from row with “Age at treatment start, years”): In the column with header: “Analysis of 12-month drug retention” and subheader: “Univariate”, the value for the odds ratio (OR) is missing. The OR should be 0.99. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85145590609&partnerID=8YFLogxK

U2 - https://doi.org/10.1016/j.semarthrit.2022.152141

DO - https://doi.org/10.1016/j.semarthrit.2022.152141

M3 - Comment/Letter to the editor

C2 - 36463635

SN - 0049-0172

VL - 58

JO - Seminars in Arthritis and Rheumatism

JF - Seminars in Arthritis and Rheumatism

M1 - 152141

ER -

Ørnbjerg LM, Linde L, Georgiadis S, Rasmussen SH, Lindström U, Askling J et al. Corrigendum to ‘Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: data from the EuroSpA collaboration’ [Seminars in Arthritis and Rheumatism 56 (2022) 1-13/152081] (Seminars in Arthritis and Rheumatism (2022) 56, (S0049017222001329), (10.1016/j.semarthrit.2022.152081)). Seminars in Arthritis and Rheumatism. 2023 Feb 1;58:152141. doi: https://doi.org/10.1016/j.semarthrit.2022.152141

Abstract

Access to Document

Other files and links

Cite this